Adam Wereszczynski was gobsmacked when tests revealed he had liver disease -he now wants to warn others about the dangers of ...

Indian scientists developed treatment for liver cirrhosis, accompanied by the distortion of both blood and lymphatic vessels ...

One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague ...

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

Fatty liver may seem harmless now, but it could silently progress to liver cancer. Know the signs, risks, and expert-backed ...

A new study by Keck Medicine School of USC finds the incidence of alcohol-related liver disease has more than doubled, ...

Researchers have revealed liver cancer cases are set to soar by 2050, with a problem on the rise in the UK driving the surge.

Left unaddressed, MASLD and MASH can progress to liver scarring, failure and, in some cases, cancer. They also increase risk of death from cardiovascular disease and liver-related complications.

The disease is marked by fat droplets piling up in liver cells, chronic inflammation and scar tissue in the liver. But a 72-week regimen of semaglutide seemed to turn the disease around.

U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...